Amgen's R&D work starts with our deep understanding of human genetics and disease biology. We collect and analyze human omics data (including data on genes, RNA and proteins) to better characterize disease, identify biomarkers and screen targets to rapidly create promising new molecules.
Using AI and other computational technologies, we predict and design precise, potential treatments. Leveraging precision medicine, we integrate genetic and environmental data to deliver more personalized therapies.
We apply our deep insights into complex biological processes to shift our approach from "find and test" to "model and design," aiming for higher success rates and faster timelines to improve patient outcomes.
